Company Name: Advanced Accelerator Applications S.A.
Advanced Accelerator Applications is a radiopharmaceutical company. The company is engaged in the development of molecular nuclear medicine (MNM) products. The company’s lead therapeutic product candidate is designed to treat midgut neuroendocrine tumors (NETs).
Ticker Symbol: AAAP (NASDAQ)
Company Website: www.adacap.com
Headquarters: Saint-Genis-Pouilly, France